Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X5LG
|
||||
| Former ID |
DIB005770
|
||||
| Drug Name |
ABJ-879
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Discontinued in Phase 1 | [547922] | ||
| Company |
Novartis AG
|
||||
| Canonical SMILES |
O1[C@]2([C@@H]1C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]<br />([C@H](CCC2)C)O)C)(C)C)O)/C(=C/c1nc(sc1)SC)/C)C
|
||||
| Target and Pathway | |||||
| Target(s) | Tubulin | Target Info | Modulator | [528961] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.